Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Mesorectal excision for rectal cancer

Abstract

Concern about world wide local recurrence rates for rectal cancer of 20-45%, together with anxiety at the recent proliferation of adjuvant therapies, led us to review the efficacy of total mesorectal excision (TME) with which no adjuvant therapy had been combined. Precise, sharp dissection is undertaken around the integral mesentery of the hind gut, which envelopes the entire mid rectum. This procedure adds to operative time and complications but has been claimed to eliminate virtually all locally recurrent disease after "curative" surgery. Independent analysis (J. K. M.) of prospective follow-up data extended over a 13-year interval (1978-91; mean 7.5 years). The actuarial local recurrence rate after curative anterior resection at 5 years is 4% (95% Cl 0-7.5%) and the overall recurrence rate is 18% (10-25%). 10-year figures are 4% (0-11%) and 19% (7-32%). In view of the high-risk classification used for the North Central Cancer Treatment Group (NCCTG), which has led to a trend to chemoradiotherapy, a similar group of high-risk Basingstoke cases was constructed for comparison purposes. This group included 135 consecutive Dukes' B (B2) and Dukes' C cancer operations, both anterior resection and abdominal-perineal excision, for tumours below 12 cm from the anal verge. Results from TME alone are substantially superior to the best reported (NCCTG) from conventional surgery plus radiotherapy or combination chemoradiotherapy: 5% local recurrence at 5 years compared with 25% and 13.…

Overview

Integrity signals

Registry

Crossref · 10.1016/0140-6736(93)90207-w

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 14 references

Cited by

See all 1,781

Metadata

Authors
MacFarlane, J. K., Ryall, R. D. H., & Heald, R. J.
Affiliations
  • University of British Columbia (CA)
  • Basingstoke and North Hampshire Hospital (GB)
Venue
The Lancet
Publisher
Elsevier BV
Published
1993-02
Volume
341
Issue
8843
Pages
457-460
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2107371365
Cited by
1,781
References
14
Citations by year
2026: 20 · 2025: 24 · 2024: 21 · 2023: 32 · 2022: 41 · 2021: 42 · 2020: 71 · 2019: 61 · 2018: 50 · 2017: 51 · 2016: 60 · 2015: 61 · 2014: 70 · 2013: 63 · 2012: 59
FWCI
12.46
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
  • Health Sciences › Medicine › Surgery › Colorectal and Anal Carcinomas
  • Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
Keywords
total mesorectal excision, rectal cancer, local recurrence, adjuvant therapy, anterior resection, high-risk classification, chemoradiotherapy, surgical outcomes
MeSH terms
Aged, Humans, Methods, Neoplasm Recurrence, Local, Rectal Neoplasms, Risk Factors, Life Tables

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mesorectal excision for rectal cancer. https://app.cochat.ai/papers/10.1016/0140-6736(93)90207-w
The paper
MacFarlane, J. K., Ryall, R. D. H., & Heald, R. J. (1993). Mesorectal excision for rectal cancer. The Lancet. https://doi.org/10.1016/0140-6736(93)90207-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.